Our data showed that administration with Gap26 during the subacute phase after cerebral ischemia deteriorated neurological deficits and downregulated dendritic spine density, indicating that Cx43 played an essential role in neurorehabilitation. This evidence concerns the gene GJA1 and brain ischemia.